Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1172-1176

Science Publishers

Access to resources Recommend Favorite

Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

By Paludan Merete   Traberg Hansen Anders   Petersen Jørgen   Grau Cai   Høyer Morten  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite

Particle therapy: a suitable alternative to stereotactic body radiotherapy for stage I non-small-cell lung cancer?

By Shibamoto Yuta  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 353-356

Future Medicine

Access to resources Recommend Favorite

Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies

By Onishi Hiroshi   Araki Tsutomu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 345-350

Oxford University Press

Access to resources Recommend Favorite